EP 1506166 B1 20111116 - AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR
Title (en)
AMINOTETRALIN-DERIVED UREA MODULATORS OF VANILLOID VR1 RECEPTOR
Title (de)
HARNSTOFFDERIVATE VON AMINOTETRALIN ALS MODULATOREN DES VANILLOID-REZEPTORS VR1
Title (fr)
MODULATEURS DE L'UREE DERIVES DE L'AMINOTETRALINE DU RECEPTEUR VANILLOIDE VR1
Publication
Application
Priority
- US 0315254 W 20030515
- US 38157502 P 20020517
Abstract (en)
[origin: WO03097586A1] This invention is directed to vanilloid receptor VR1 ligands of formula (1). More particularly, this invention relates to beta-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
IPC 8 full level
C07C 275/26 (2006.01); C07D 233/64 (2006.01); A61K 31/17 (2006.01); A61K 31/36 (2006.01); A61K 31/4164 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/00 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 25/04 (2006.01); A61P 25/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 39/02 (2006.01); A61P 43/00 (2006.01); C07C 275/28 (2006.01); C07C 275/32 (2006.01); C07C 335/14 (2006.01); C07D 213/36 (2006.01); C07D 213/40 (2006.01); C07D 215/38 (2006.01); C07D 217/02 (2006.01); C07D 217/08 (2006.01); C07D 217/22 (2006.01); C07D 217/24 (2006.01); C07D 233/54 (2006.01); C07D 237/28 (2006.01); C07D 239/74 (2006.01); C07D 307/52 (2006.01); C07D 317/58 (2006.01); C07D 317/66 (2006.01); C07D 333/20 (2006.01); C07D 333/32 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP US)
A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/14 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 39/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 275/26 (2013.01 - EP US); C07C 275/28 (2013.01 - EP US); C07C 275/32 (2013.01 - EP US); C07C 335/14 (2013.01 - EP US); C07D 213/40 (2013.01 - EP US); C07D 215/38 (2013.01 - EP US); C07D 217/02 (2013.01 - EP US); C07D 217/08 (2013.01 - EP US); C07D 217/22 (2013.01 - EP US); C07D 217/24 (2013.01 - EP US); C07D 233/64 (2013.01 - EP US); C07D 237/28 (2013.01 - EP US); C07D 239/74 (2013.01 - EP US); C07D 307/52 (2013.01 - EP US); C07D 317/58 (2013.01 - EP US); C07D 333/20 (2013.01 - EP US); C07D 333/32 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 405/12 (2013.01 - EP US); C07D 409/12 (2013.01 - EP US); C07D 471/04 (2013.01 - EP US); C07C 2601/02 (2017.04 - EP US); C07C 2602/10 (2017.04 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03097586 A1 20031127; AR 039823 A1 20050302; AT E533743 T1 20111215; AU 2003241453 A1 20031202; CA 2486092 A1 20031127; EP 1506166 A1 20050216; EP 1506166 B1 20111116; JP 2005526137 A 20050902; TW 200406375 A 20040501; US 2003236280 A1 20031225; US 2005187291 A1 20050825; US 2008097102 A1 20080424; US 2010125140 A1 20100520; US 6984647 B2 20060110; US 7678812 B2 20100316; US 8569505 B2 20131029
DOCDB simple family (application)
US 0315254 W 20030515; AR P030101730 A 20030516; AT 03731189 T 20030515; AU 2003241453 A 20030515; CA 2486092 A 20030515; EP 03731189 A 20030515; JP 2004505319 A 20030515; TW 92113274 A 20030516; US 43847703 A 20030515; US 4595605 A 20050128; US 69212810 A 20100122; US 87722007 A 20071023